Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Entrapment Neuropathy Evaluation Athena Diagnostics United States | 3 | 2 |
|
Athena Diagnostics United States | 2 | 1 |
|
PMP22 Duplication/Deletion DNA Test Athena Diagnostics United States | 2 | 1 |
|
Athena Diagnostics United States | 2 | 1 |
|
CMT Advanced Evaluation - Demyelinating Athena Diagnostics United States | 22 | 15 |
|
CMT Advanced Evaluation - Comprehensive Athena Diagnostics United States | 31 | 23 |
|
CMT Advanced Evaluation - Dominant, Demyelinating Athena Diagnostics United States | 10 | 6 |
|
CMT Advanced Evaluation - Dominant Athena Diagnostics United States | 18 | 13 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Charcot-Marie-Tooth Neuropathy Type 1E (PMP22) MVZ Dr. Eberhard & Partner Dortmund Germany | 2 | 1 |
|
Hereditary Neuropathies NGS Panel Fulgent Genetics United States | 91 | 38 |
|
MedGene Slovakia | 1 | 1 |
|
Praxis fuer Humangenetik Wien Austria | 1 | 1 |
|
Charcot-Marie-Tooth Neuropathy Type 1E MGZ Medical Genetics Center Germany | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.